You are here

Sildenafil Citrate for the Treatment of Established Pre-Eclampsia

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Pembury, Kent, TN2 4QJ United Kingdom
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pre-Eclampsia
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects with pre-eclampsia defined as new hypertension with a diastolic BP of > or =
90 mmHg on two occasions separated by at least 4 hrs arising after 20 weeks of
pregnancy, associated with >500 mg/24 hr proteinuria. Subjects with pre-existing
hypertension (on treatment) need only fulfill proteinuria requirement.

- Gestational age 24-34 w

- Singleton pregnancy

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Where urgent delivery is indicated

- Where the fetus is suspected to have a structural or chromosomal abnormality

NCT00141310
Pfizer
Terminated
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now